Suppliers / Vitalife Laboratories (A Div Arch Pharmalabs

Vitalife Laboratories (A Div Arch Pharmalabs

India Updated 9 July 2026

Vitalife Laboratories (A Div Arch Pharmalabs is an API manufacturer based in India. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 3 molecules. Its most recent recorded inspection, by US FDA, closed on 4 March 2019 as NAI.

2
active US DMFs
1
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 4 March 2019 NAI US FDA
  • 1 April 2015 NAI US FDA
  • 12 April 2013 VAI US FDA
  • 20 November 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Mumbai, India Not on file
Gurugram, India 3005674618

What they file, and where

Molecule Regulators Docs
Clopidogrel US FDA 2
Caspofungin SFDA (Saudi Arabia) 1
Trandolapril EDQM 1

Also appears on these molecule pages

Caspofungin API Clopidogrel API

Questions about Vitalife Laboratories (A Div Arch Pharmalabs

Does Vitalife Laboratories (A Div Arch Pharmalabs hold a US DMF or a CEP?
Vitalife Laboratories (A Div Arch Pharmalabs holds 2 active US drug master files and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Vitalife Laboratories (A Div Arch Pharmalabs FDA-registered?
One site operated by Vitalife Laboratories (A Div Arch Pharmalabs carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Vitalife Laboratories (A Div Arch Pharmalabs's last inspection go?
The most recent inspection on record closed on 4 March 2019 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Vitalife Laboratories (A Div Arch Pharmalabs manufacture?
2 registered sites are on record, in India (Mumbai and Gurugram). Every site is listed on this page with the register it came from.
What does Vitalife Laboratories (A Div Arch Pharmalabs make?
3 molecules are on record against Vitalife Laboratories (A Div Arch Pharmalabs, including Clopidogrel, Caspofungin and Trandolapril. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Vitalife Laboratories (A Div Arch Pharmalabs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 4 March 2019.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Hetero shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Zydus Lifesciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability